Research ArticleClinical Studies
Prognostic Markers for Patient Outcome Following Vaccination with Multiple MHC Class I/II-restricted WT1 Peptide-pulsed Dendritic Cells Plus Chemotherapy for Pancreatic Cancer
KAZUKI TAKAKURA, SHIGEO KOIDO, SHIN KAN, KOSAKU YOSHIDA, MASAKO MORI, YUTA HIRANO, ZENSHO ITO, HIROKO KOBAYASHI, SHINICHIRO TAKAMI, YOSHIHIRO MATSUMOTO, MIKIO KAJIHARA, TAKEYUKI MISAWA, MASATO OKAMOTO, HARUO SUGIYAMA, SADAMU HOMMA, TOSHIFUMI OHKUSA and HISAO TAJIRI
Anticancer Research January 2015, 35 (1) 555-562;